Exploration of prognosis and immunometabolism landscapes in ER+ breast cancer based on a novel lipid metabolism-related signature

INTRODUCTION: Lipid metabolic reprogramming is gaining attention as a hallmark of cancers. Recent mounting evidence indicates that the malignant behavior of breast cancer (BC) is closely related to lipid metabolism. Here, we focus on the estrogen receptor-positive (ER+) subtype, the most common subg...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Lesang, Huang, Huanhuan, Li, Jiaxin, Chen, Wuzhen, Yao, Yao, Hu, Jianming, Zhou, Jun, Huang, Fengbo, Ni, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352658/
https://www.ncbi.nlm.nih.gov/pubmed/37469520
http://dx.doi.org/10.3389/fimmu.2023.1199465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352658/
https://www.ncbi.nlm.nih.gov/pubmed/37469520
http://dx.doi.org/10.3389/fimmu.2023.1199465

Ejemplares similares